跳至主要内容
临床试验/NCT01373645
NCT01373645已完成2 期

Safety and Efficacy Registry of Yinyi Polymer-free Paclitaxel-eluting Stent

Shanghai Jiao Tong University School of Medicine1 个研究点 分布在 1 个国家目标入组 1,045 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
1,045
试验地点
1
主要终点
major adverse cardiac events

研究概览

简要总结

Drug-eluting stents effectively reduce restenosis but may increase late thrombosis and delayed restenosis. Persistent polymer could be responsible. Local delivery of paclitxel from a polymer-free Yinyi stent (Dalian Yinyi biomaterial research and development co.ltd) may prevent these complications.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18-80 years old
  • both gender
  • native coronary lesion
  • narrowing > 70%
  • vessel size 2.5-4.0 in diameter

排除标准

  • without informed consent,
  • ST elevation myocardial infarction within 7 days,
  • patient with ≤ 70% coronary narrowing at target lesion,
  • left main lesion,
  • multivessel narrowing need more than 3 stent implantations,
  • by-pass graft,
  • abnormal liver function before randomization,
  • active hepatitis or muscular disease,
  • impaired renal function with serum creatinine level > 3mg/dl,
  • impaired left ventricular function with LVEF < 30%,
  • Participate in other studies.

结局指标

主要结局

major adverse cardiac events

时间窗: 12 months

including cardiac death, myocardial infarction and target vessel failure

次要结局

  • stent thrombosis(12 months)

研究者

发起方
Shanghai Jiao Tong University School of Medicine
申办方类型
Other

研究点 (1)

Loading locations...

相似试验